4.6 Article

Serum Cholesterol Concentration and Prevalence, Awareness, Treatment, and Control of High Low-Density Lipoprotein Cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg

Journal

Publisher

WILEY
DOI: 10.1161/JAHA.113.000650

Keywords

cholesterol; epidemiology; hypercholesterolemia; low-density lipoprotein cholesterol

Funding

  1. Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST) [2010-0028367]

Ask authors/readers for more resources

Background-The mortality rate from cardiovascular disease (CVD) among young adults has declined less than that in the older population, raising concerns about the increasing prevalence of obesity-related conditions including hypercholesterolemia in the younger population. We investigated the age-standardized mean levels of serum cholesterols and the prevalence, awareness, treatment and control rates of hyper-low-density lipoprotein (LDL)-cholesterolemia based on age. Methods and Results-Nationally representative samples of 19 489 subjects aged >= 20 years were analyzed from the Korea National Health and Nutrition Examination Surveys 2008-2010. Hyper-LDL-cholesterolemia was individually evaluated by the 2004 National Cholesterol Education Program Adult Treatment Panel III guidelines. Age-standardized mean levels of total cholesterol, high-density lipoprotein-cholesterol, LDL-cholesterol, and triglycerides were 186.8, 48.0, 112.9, and 136.0 mg/dL, respectively. Age-standardized prevalence of hyper-LDL-cholesterolemia was 23.2% (men, 25.5%; women, 21.8%). Among subjects with hyper-LDL-cholesterolemia, awareness and treatment rates were significantly lower in younger adults (<50 years) compared to older adults >= 50 years (awareness, 8.0% versus 21.5%; treatment, 5.1% versus 18.5%, all Ps<0.001), indicating significant discrepancies in awareness and treatment rates of hypercholesterolemia between younger and older adults. Among subjects aware of their hyper-LDL-cholesterolemia, younger adults were more likely to have controlled LDL-cholesterol than the elderly (82.1% versus 67.5%, P<0.001). Conclusions-Compared to the elderly, significant proportions of young and middle-aged adults are unaware of their hypercholesterolemia and are not treated with proper lipid-lowering medications. Early screening, education, and proper management should be stressed in national public healthcare policies to reduce the increasing burden of CVD in the younger population with undiagnosed hypercholesterolemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008-2018

Dong-Hyuk Park, Seon Young Goo, Sung Hyun Hong, Ji-hee Min, Ji Yong Byeon, Mi-Kyung Lee, Hae Dong Lee, Byoung Wook Ahn, Heejin Kimm, Sun Ha Jee, Dong Hoon Lee, Yong-ho Lee, Eun Seok Kang, Justin Y. Jeon

Summary: This study aimed to investigate the association between resting heart rate (RHR) and the prevalence of undiagnosed diabetes. The results showed that participants with higher RHR had a significantly higher prevalence of undiagnosed diabetes, and this association was stronger among younger and leaner individuals. Therefore, RHR can be used as an indicator to identify and prevent undiagnosed diabetes.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Article Endocrinology & Metabolism

?-hydroxybutyrate as a biomarker of ?-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months

Minyoung Lee, Yongin Cho, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee

Summary: This study investigated the clinical relevance of ketone bodies in newly diagnosed type 2 diabetes patients. The results showed that patients with higher initial serum β-hydroxybutyrate (BHB) levels had greater improvement in glycemic control after 6 months of anti-diabetic treatment, as indicated by lower HbA1c levels and better blood sugar control.

DIABETES & METABOLISM (2023)

Article Endocrinology & Metabolism

Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial

Yong-ho Lee, Doo-Man Kim, Jae Myung Yu, Kyung Mook Choi, Sin Gon Kim, Kang Seo Park, Hyun-Shik Son, Choon Hee Chung, Kyu Jeung Ahn, Soon Hee Lee, Ki-Ho Song, Su Kyoung Kwon, Hyeong Kyu Park, Kyu Chang Won, Hak Chul Jang

Summary: This study compared the effects of anagliptin 100 mg BID versus sitagliptin 100 mg QD on managing glycaemic variability and found that the anagliptin BID regimen was superior in blood glucose control after dinner, as indicated by MAGE and TIR, but was equivalent to the QD regimen in terms of HbA1c and FPG.

DIABETES OBESITY & METABOLISM (2023)

Article Cardiac & Cardiovascular Systems

Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

Yong-Joon Lee, Jae Young Cho, Seng Chan You, Yong-Ho Lee, Kyeong Ho Yun, Yun-Hyeong Cho, Won-Yong Shin, Sang Wook Im, Woong Chol Kang, Yongwhi Park, Sung Yoon Lee, Seung-Jun Lee, Sung-Jin Hong, Chul-Min Ahn, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Jung-Sun Kim

Summary: This study evaluated the effect of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy among patients with diabetes mellitus and atherosclerotic cardiovascular disease. The study found that the combination therapy had similar outcomes in terms of cardiovascular events compared to the monotherapy, but had a higher rate of intolerance-related discontinuation or dose reduction. However, the combination therapy was more effective in achieving lower LDL cholesterol levels.

EUROPEAN HEART JOURNAL (2023)

Article Endocrinology & Metabolism

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes

Sejeong Lee, Jaehyun Bae, Doo Ri Jo, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee

Summary: In newly diagnosed type 2 diabetes patients, intact ketogenesis may be associated with a decreased risk of metabolic-associated fatty liver disease (MAFLD).

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Medicine, General & Internal

Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018

Sun Ok Song, Eugene Han, Kang Ju Son, Bong-Soo Cha, Byung-Wan Lee

Summary: This study investigates whether mortality trends have changed in individuals with type 2 diabetes and kidney transplantation (KT), and found that the age at death of KT recipients has been increasing. The age at KT was higher in patients with type 2 diabetes and was the main contributor to the age at death in KT recipients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Endocrinology & Metabolism

Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis

Hye Jin Chun, Eun Ran Kim, Minyoung Lee, Da Hyun Choi, Soo Hyun Kim, Eugene Shin, Jin-Hong Kim, Jin Won Cho, Dai Hoon Han, Bong-Soo Cha, Yong-ho Lee

Summary: The aim of this study was to investigate the mechanism by which SGLT2 inhibitors reduce steatosis in NASH patients. The results showed that SGLT2 expression and O-GlcNAcylation were increased in the livers of NASH patients. In vitro and in vivo experiments demonstrated that SGLT2 inhibitor treatment reduced hepatocellular glucose uptake and promoted autophagy, leading to alleviation of lipid accumulation, inflammation, and fibrosis in NASH.

METABOLISM-CLINICAL AND EXPERIMENTAL (2023)

Article Medicine, General & Internal

Calf Circumference as an Indicator for Cystatin C Testing in Hospitalized Elderly Male Patients for Detecting Hidden Renal Impairment

Sunghwan Lee, Seul Lee, Sunhee Jo, Kyung-Ah Kim, Yu Jin Yang, Jung Joo Lee, Eunsung Kim, Yongjung Park, Taeyoung Kyong, Jeong-Ho Kim

Summary: Serum creatinine levels can overestimate renal function in elderly patients with sarcopenia. This study examined calf circumference (CC) as a potential indicator to test for cystatin C instead of creatinine in elderly inpatients. The results showed a positive correlation between CC and the eGFRcys/eGFRcr ratio in both sexes, suggesting that CC could be a cost-effective screening tool for detecting hidden renal impairment in elderly male patients using cystatin C as an add-on test.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Multidisciplinary Sciences

Muscle mass has a greater impact on serum creatinine levels in older males than in females

Jisook Yim, Nak-Hoon Son, Taeyoung Kyong, Yongjung Park, Jeong-Ho Kim

Summary: This study analyzed the effects of age and sex on the relationship between muscle mass and serum creatinine levels. The results showed a significant negative correlation between serum creatinine levels and age in males, but not in females. This suggests that the decline in muscle mass has a more significant impact on serum creatinine levels in older males.

HELIYON (2023)

Article Multidisciplinary Sciences

Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons

Seul Ki Kim, Le Trung Tran, Cherl NamKoong, Hyung Jin Choi, Hye Jin Chun, Yong-ho Lee, MyungHyun Cheon, ChiHye Chung, Junmo Hwang, Hyun-Ho Lim, Dong Min Shin, Yun-Hee Choi, Ki Woo Kim

Summary: The mitochondrial-derived peptide SHLP2 plays a crucial role in energy homeostasis by activating hypothalamic neurons and binding to CXCR7. It protects against obesity and improves insulin sensitivity in mice fed a high-fat diet.

NATURE COMMUNICATIONS (2023)

Article Endocrinology & Metabolism

Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial

Yong-Joon Lee, Sang-Hyup Lee, Seng Chan You, Yong-ho Lee, Seung-Jun Lee, Sung-Jin Hong, Chul-Min Ahn, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Jung-Sun Kim

Summary: The study evaluated the safety and efficacy of a moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome (MetS) and atherosclerotic cardiovascular disease. The combination therapy showed comparable cardiovascular benefits with lower drug intolerance and low-density lipoprotein cholesterol levels compared to monotherapy, but no significant difference in new-onset diabetes.

DIABETES OBESITY & METABOLISM (2023)

Article Multidisciplinary Sciences

Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons

Seul Ki Kim, Le Trung Tran, Cherl NamKoong, Hyung Jin Choi, Hye Jin Chun, Yong-ho Lee, MyungHyun Cheon, ChiHye Chung, Junmo Hwang, Hyun-Ho Lim, Dong Min Shin, Yun-Hee Choi, Ki Woo Kim

Summary: Small humanin-like peptide 2 (SHLP2), a mitochondrial-derived peptide, plays a crucial role in energy homeostasis. The study demonstrates that SHLP2 can protect mice from high-fat diet-induced obesity and improve insulin sensitivity. It activates pro-opiomelanocortin (POMC) neurons in the hypothalamus, which suppresses food intake and promotes thermogenesis. The researchers also discover that SHLP2 binds to and activates chemokine receptor 7 (CXCR7).

NATURE COMMUNICATIONS (2023)

No Data Available